11-108315883-GGA-CGT
Variant summary
The NM_000051.4(ATM):c.6067_6069delGGAinsCGT (p.Gly2023Arg) variant causes a missense change. The gene ATM is a tumor suppressor gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a known oncogene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a cancer driver gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.47). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.G2023E: Uncertain_significance (ClinVar VariationId 453610, 2 stars); p.G2023= (synonymous): Likely_benign (ClinVar VariationId 1751358, 1 star); p.G2023R: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127416); p.G2023R: Benign (ClinVar VariationId 2127852, 1 star); p.G2023V: Uncertain_significance (ClinVar VariationId 3801988, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Ataxia telangiectasia (AT).
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
- ATM-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Natera, Ambry Genetics
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, G2P, Orphanet, Natera, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| B2Does not fit gene mode of action | Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context); Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATM | MANE Select | c.6067_6069delGGAinsCGT p.Gly2023Arg | missense | N/A | Prot: NP_000042.3 | |
ATM | c.6067_6069delGGAinsCGT p.Gly2023Arg | missense | N/A | Prot: NP_001338763.1 UniProt: | ||
C11orf65 | c.641-6814_641-6812delTCCinsACG | intron | Intron 6 of 6 | Prot: NP_001317297.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATM | MANE Select | c.6067_6069delGGAinsCGT p.Gly2023Arg | missense | N/A | Prot: ENSP00000501606.1 UniProt: | |
ATM | TSL:1 | c.6067_6069delGGAinsCGT p.Gly2023Arg | missense | N/A | Prot: ENSP00000388058.2 UniProt: | |
ATM | TSL:1 | n.*1131_*1133delGGAinsCGT | 3_prime_UTR | Exon 39 of 61 | Prot: ENSP00000435747.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 2 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Pathogenic | 9.5 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.